Advertisement
Canada markets open in 6 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7293
    -0.0027 (-0.37%)
     
  • CRUDE OIL

    82.85
    -0.51 (-0.61%)
     
  • Bitcoin CAD

    90,633.62
    -53.53 (-0.06%)
     
  • CMC Crypto 200

    1,429.96
    +5.86 (+0.41%)
     
  • GOLD FUTURES

    2,337.10
    -5.00 (-0.21%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.6400
    +0.0420 (+0.91%)
     
  • NASDAQ futures

    17,701.00
    +94.25 (+0.54%)
     
  • VOLATILITY

    15.88
    +0.19 (+1.21%)
     
  • FTSE

    8,074.31
    +29.50 (+0.37%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6815
    -0.0021 (-0.31%)
     

Most Analysts Recommend a ‘Buy’ for Aurora Cannabis

Most Analysts Recommend a ‘Buy’ for Aurora Cannabis

Aurora Cannabis (ACB) (ACBFF) stock rose by 9.9% to its highest level of 15.1 Canadian dollars on October 15. With just one more day until recreational cannabis will be sold legally in Canada, investors (HMLSF) are hopeful that Aurora Cannabis will emerge as a strong player. Overall, the current consensus analyst recommendation for Aurora Cannabis in October is a “buy,” which remained unchanged from September.